JAMIE TAYLOR: Open Payments
NPI 1326521873 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 10 payments from 3 companies in 2025. Trend: 2023 $385 · 2024 $529 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $160 |
| ACADIA Pharmaceuticals Inc | 2 | $128 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
Products named: INGREZZA, NUPLAZID, REXULTI.
Industry payments across CT — which companies pay providers there.
